With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, ...
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...
CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in ...
Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
Achieves ISO9001, EFfCI GMP, and EXCiPACT certifications for its new manufacturing plant.
Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...
With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...